About Proton Therapy

Cancer is responsible for an estimated 10 million deaths globally.

The incidence of cancer is growing and it is estimated by the National Cancer Registry that it will increase by 111% from 2015- 2045

In Ireland alone, 1 in 2 people will develop cancer during their lifetime and more than 40,000 new cases of cancer or related tumours are diagnosed each year.

Standard Treatment of Care Protocol for Cancer at present includes Surgery, Chemotherapy and Radiotherapy.

50% of patients are deemed suitable for Radiotherapy, but as a treatment, its effectiveness is limited by the considerable, unavoidable collateral damage its use causes to the human body.

Proton Therapy is a clinically-proven and advanced form of radiotherapy treatment for cancer which uses high-energy, precision-focused particle beams to precisely target tumours, with minimal impact on surrounding healthy tissue and organs. Proton Therapy delivers:

  • Reduced side effects and toxicities by protecting surrounding tissue and vital organs.
  • Reduced complications and risk of secondary cancers
  • Shorter treatment courses compared to standard radiotherapy
  • Cost savings for patients and healthcare systems

Clinically, Proton Therapy is the preferred treatment for many cancers in children, who are particularly sensitive to radiation damage and for some cancers near the brain and spinal cord. Clinical studies have also demonstrated efficacy to improve quality of life outcomes in the treatment of prostate cancer.

Our Team

Jianjing Gao

Muir PT - Founder & President

Jianjing Gao is co-founder and President of Muir PT, where she spearheads the disruptive innovation business model of Muir to redefine HealthCare 4.0.

She is a graduate of Greenwich University, and is a student of Professor Clayton Christiansen’s Harvard Business School’s Disruptive Innovation program.

Together with Kevin Paul, JianJing has assembled a team of leaders, innovators and healthcare partners to deliver Affordable, Accessible and Available Proton Therapy to patients.

Kevin Paul

Muir Innovation - Founder & CEO

Kevin Paul is founder and CEO of Muir Innovation. Kevin leads innovation and engineering specialities at Muir PT and is a serial entrepreneur.

He is a civil and mechanical engineer and Harvard executive alumni.

Kevin founded SMC his first company after graduating from UCC in 1984. He sold it to Kentz Technologies in 1990, becoming founding CEO of Kentz Technologies in the process.

Tim Field

Muir PT - CDO

Tim Field is the Chief Development Officer of Muir PT, with primary responsibility for corporate finance and development matters.

Tim has had a long and distinguished career in corporate finance, originally as a corporate finance and capital markets lawyer in the City of London. He has more than twenty years’ experience as an equity partner and has held senior management roles in a number of large international law firms. He has led corporate deals with an aggregate value exceeding a hundred billion pounds sterling.

More recently he is the founder of the investment firm Absolutely Capital, as well as the corporate and securities law firm Field. He is a non-executive director of a UK listed company and various private companies in which Absolutely Capital is interested.

Benno Beuting

Muir PT - COO

Benno Beuting was appointed Chief Operating Officer of Muir PT in July 2019. He joined the company as Vice President, Robotics and Automation in 2016.

He is the founder of Cordis, a low-code software company with offices in the Netherlands and Spain. Its main product ‘Cordis SUITE’ is a low-code software development platform for machine-control applications used by high-tech companies such as Philips, ASML and Altran/Capgemini.

Benno has over 25 years’ experience in the control of mechatronic systems and is an industry leader in the digitalization of these systems; mastering Fourth Industrial Revolution concepts. He holds master’s degrees in Mechatronics, Robotics and Automation Engineering.

Mark Ennis

Muir PT - Strategy Director

Mark Ennis is Strategy Director of Muir PT, with primary responsibility for corporate strategies.

He has over 35 years experiences at Board level in both the public and private sectors.

Currently he serves as Non-Executive Chairman of SSE Ireland, the second largest energy utility in Ireland and part of the FTSE-listed SSE plc. He has served as a Non-Executive Director on many boards in both the Financial, Medical, Printing and Packaging and Industrial sectors and currently sits as on the Boards of W&G Baird and Wilson Biochemical Ltd.

Mark has most recently been Chairman of Invest NI (the inward investment organisation for Northern Ireland) where he held the position from 2011 until 2019.  

Prior to joining the Energy sector with Airtricity Ltd, Mark was a Senior Vice President of Chesapeake Corporation a fortune 500 company and CEO of Boxmore International PLC. Mark was made a CBE in the Queen’s Birthday Honours List in 2016 for services to the economy and community in Northern Ireland.

To know More About Company Details Please

Log in Sign Up

Contact Us


Muir PT
N.S.C. Campus,
Mahon, Cork
T12 XY2N, Ireland



Your message has been sent. Thank you!